We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters to the Editor |

Tailoring Treatment to Parental Values: A Comment on TADS

David Antonuccio, PhD
Arch Gen Psychiatry. 2008;65(6):723. doi:10.1001/archpsyc.65.6.723-a.
Text Size: A A A
Published online


When considering efficacy, the Treatment for Adolescents With Depression Study (TADS),1 in my view the best comparative study ever done in children with depression, ranks the acute outcome of the treatments from best to worst this way: combination treatment, followed by fluoxetine hydrochloride therapy alone, followed by cognitive behavior therapy (CBT) alone, followed by placebo. Analysis of longer-term efficacy2 suggests that CBT caught up with fluoxetine therapy at the 18-week follow-up and CBT caught up with the combination treatment at the 36-week follow-up (81% response for CBT, 81% response for fluoxetine therapy, and 85% response for combination treatment). When considering safety, the acute treatment rankings from best to worst were entirely different1: CBT alone was best, followed by placebo, followed by combination treatment, followed by fluoxetine therapy alone. These safety rankings were maintained (suicidal events were 6.3% in CBT, 8.4% in combination treatment, and 14.7% in fluoxetine therapy [not reported for placebo]) at follow-up,2 though combination treatment crept closer to CBT. What's a clinician to do? One possibility is to empower parents to make informed choices about treatment consistent with their own values by giving them this information on risk and benefit and letting them decide.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.